Literature DB >> 22948201

The anatomical and electrophysiological subthalamic nucleus visualized by 3-T magnetic resonance imaging.

Parag G Patil1, Erin C Conrad, J Wayne Aldridge, Thomas L Chenevert, Kelvin L Chou.   

Abstract

BACKGROUND: Accurate localization of the subthalamic nucleus (STN) is critical to the success of deep brain stimulation surgery for Parkinson disease. Recent developments in high-field-strength magnetic resonance imaging (MRI) have made it possible to visualize the STN in greater detail. However, the relationship of the MR-visualized STN to the anatomic, electrophysiological, or atlas-predicted STN remains controversial.
OBJECTIVE: To evaluate the size of the STN visualized on 3-T MRI compared with anatomic measurements in cadaver studies and to compare the predictions of 3-T MRI and those of the Schaltenbrand-Wahren (SW) atlas for intraoperative STN microelectrode recordings.
METHODS: We evaluated the STN by 3-T MRI and intraoperative microelectrode recordings in 20 Parkinson disease patients undergoing deep brain stimulation surgery. We compared our findings with anatomic cadaver studies and with the individually scaled SW atlas-based predictions for each patient.
RESULTS: The dimensions of the 3-T MR-visualized STN were very similar to those of the largest anatomic study (MRI length, width, and height: 9.8 ± 1.6, 11.5 ± 1.6, and 3.7 ± 0.7 mm, respectively; n = 40; cadaver length, width, and height: 9.3 ± 0.7, 10.6 ± 0.9, and 3.1 ± 0.5 mm, respectively; n = 100). The amount of STN traversed during intraoperative microelectrode recordings was better correlated to the 3-T MR-visualized STN than the SW atlas-predicted STN (R = 0.38 vs R = -0.17).
CONCLUSION: The STN as visualized on 3-T MRI corresponds well with cadaveric anatomic studies and intraoperative electrophysiology. STN visualization with 3-T MRI may be an improvement over SW atlas-based localization for STN deep brain stimulation surgery in Parkinson disease.

Entities:  

Mesh:

Year:  2012        PMID: 22948201     DOI: 10.1227/NEU.0b013e318270611f

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Lateralization of the Subthalamic Nucleus with Age in Parkinson's Disease.

Authors:  Julio L B Pereira; Sydney Furie B A; Justin Sharim; Daniel Yazdi; Antonio A F DeSalles; Nader Pouratian
Journal:  Basal Ganglia       Date:  2016-04-01

2.  A Computerized Microelectrode Recording to Magnetic Resonance Imaging Mapping System for Subthalamic Nucleus Deep Brain Stimulation Surgery.

Authors:  Sunjay S Dodani; Charles W Lu; J Wayne Aldridge; Kelvin L Chou; Parag G Patil
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-06-01       Impact factor: 2.703

3.  Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.

Authors:  James M Mossner; Parag G Patil; Kelvin L Chou
Journal:  J Neural Transm (Vienna)       Date:  2019-09-07       Impact factor: 3.575

4.  The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Kelvin L Chou; Jennifer L Taylor; Parag G Patil
Journal:  Parkinsonism Relat Disord       Date:  2013-07-10       Impact factor: 4.891

5.  Stimulation of zona incerta selectively modulates pain in humans.

Authors:  Charles W Lu; Daniel E Harper; Asra Askari; Matthew S Willsey; Philip P Vu; Andrew D Schrepf; Steven E Harte; Parag G Patil
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

6.  General Anesthesia versus Local Anesthesia in StereotaXY (GALAXY) for Parkinson's disease: study protocol for a randomized controlled trial.

Authors:  R A Holewijn; D Verbaan; R M A de Bie; P R Schuurman
Journal:  Trials       Date:  2017-09-07       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.